Handelsavisen
prelaunch
Companies Healthcare 1833.HK
18
1833.HK HKEX Healthcare Facilities & Services

Ping AN Healthcare and Technology Co Ltd

HK$9,59
Open in Charts → Attach watcher ⌖
HKD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
5,0 %
ROE
3,8 %
Net margin
6,9 %
Debt / equity
0,01
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Ping An Healthcare and Technology Co Ltd provides healthcare services and technology solutions, primarily generating revenue through medical services, health management, and insurance-linked healthcare offerings.

Business. Ping AN Healthcare and Technology Co Ltd (1833.HK) is a healthcare services and equipment company primarily engaged in biotechnology activities within the healthcare facilities and services industry. The firm operates on a service-revenue model, focusing on healthcare-related services and technological solutions. Headquartered in China, the company is listed on the Hong Kong Stock Exchange under the ticker 1833.HK. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityBiotechnology
Generated · model-assisted
Sell-side consensus
BUY14 analysts
7 buy5 hold2 sell
Avg 12m price target15,46

Analyst recommendations

14 analysts · consensus Buy
Buy7
Hold5
Sell2
12-month price target
15,46
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
14 analysts · indicative
Ownership
not yet wired
Profitability
3,8 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 1833.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 1833.HK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Ping AN Healthcare and Technology Co Ltd (1833.HK) is a healthcare services and equipment company primarily engaged in biotechnology activities within the healthcare facilities and services industry. The firm operates on a service-revenue model, focusing on healthcare-related services and technological solutions. Headquartered in China, the company is listed on the Hong Kong Stock Exchange under the ticker 1833.HK. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityBiotechnology
    AI synthesis
    GENERATED

    Ping An Healthcare and Technology Co Ltd maintains a strong liquidity position, with a current ratio of 2.7 and cash and equivalents of CNY 1.23 billion. The company's debt-to-equity ratio is 0.01, indicating a conservative capital structure with minimal leverage. Despite a negative free cash flow of CNY -3.49 billion, the company's operating cash flow of CNY 450.95 million supports ongoing operations.

    The company's profitability metrics are below the industry median for healthcare services. Return on equity (ROE) is 3.83%, and return on assets (ROA) is 2.87%. These figures suggest that the company is not generating returns at a level that outperforms the industry average, which may be a concern for investors seeking high returns in a competitive sector.

    Ping An Healthcare and Technology Co Ltd's revenue is concentrated in a few key segments, with the majority of its revenue derived from medical services and health management. The company's geographic exposure is primarily within China, with limited international operations. This concentration may expose the company to regional economic and regulatory risks.

    The company's growth trajectory is modest, with revenue of CNY 5.47 billion in the latest reporting period. Analysts have provided a mean price target of CNY 15.46, with a median of CNY 14.50, indicating a generally positive outlook. However, the wide range of price targets (CNY 9.40 to CNY 23.88) suggests some uncertainty in the market regarding the company's future performance.

    The company's risk profile is relatively low, with no immediate liquidity or dilution flags detected. The low dilution risk is supported by the fact that the number of shares outstanding has not changed between basic and diluted shares, indicating no imminent threat of share dilution. The company's conservative capital structure and strong liquidity position further mitigate financial risk.

    Recent events, including analyst estimates and price targets, suggest a mixed but generally positive sentiment among investors. The mean recommendation of 2.36 (on a scale of 1 to 5) indicates a slight bias toward a "buy" rating, with four strong-buy and three buy recommendations. These signals suggest that the company is viewed as a potential growth opportunity, though with some caution.

    Key takeaways
    • Ping An Healthcare and Technology Co Ltd maintains a conservative capital structure with a low debt-to-equity ratio of 0.01.
    • The company's ROE and ROA are below the industry median, indicating subpar profitability.
    • Revenue is concentrated in domestic healthcare services, with limited international diversification.
    • Analysts have a generally positive outlook, with a mean price target of CNY 15.46.
    • The company's liquidity and dilution risks are low, supported by a strong cash position and stable share count.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    HK$9,59
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    HK$9.92B
    Net cash
    HK$1.18B
    Current ratio
    2.7
    Debt / equity
    0.0
    ROA
    2.9%
    ROE
    3.8%
    Cash conversion
    119.0%
    CapEx / revenue
    -0.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Care Management Services
    low · llm_fanout_v2
    Health Financial Services
    low · llm_fanout_v2

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    0,21
    Predicted surprise
    -0,00
    Beat probability
    45 %
    Analysts
    14
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-20 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate0,21
    Revenueno estimateno estimate6,0B CNY
    Operating incomeno estimateno estimate285,0M CNY
    Full-year consensus mean (period as reported by source) · consensus in CNY. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution14 analysts
    Strong buy4
    Buy3
    Hold5
    Sell2
    Strong sell0
    12-month price targetHK$15,46 · Median HK$14,50
    Low HK$9,40High HK$23,88
    Operating income · consensus285,0M CNY
    EPS surprise
    −4,7 %
    reported vs consensus · miss
    Revenue surprise
    −9,3 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    LowHK$9,40
    MeanHK$15,46
    MedianHK$14,50
    HighHK$23,88
    SpotHK$9,59
    +61.2 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin5,0 %Below median
    Net Margin6,9 %Above median
    ROE3,8 %Below median
    Capex / Rev-0,7 %Above P75
    D/E0,01Above P75
    Cash Conv1,19Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Ping AN Healthcare and Technology Co Ltd Market data — financials · 2026-05-26
    • Ping AN Healthcare and Technology Co Ltd Market data — analyst estimates · 2026-05-26
    • Ping AN Healthcare and Technology Co Ltd Market data — ESG · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    1833.HKCanonical
    HKEX · HKD

    Intel & risk

    PredictorBeat prob45 %Surprise-0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage